Evidence map›Paper›PMID 29568555›Full record

ArticleJournal of virus eradication2018

Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9-11 November 2017, Rome, Italy.

P Zangari, P Palma, N Cotugno, P Rojo, A Tagarro, I Pepponi, A De Rossi, L Kuhn, S Pahwa, M Cameron and 12 more

Abstract readEditorial
In one paragraph

Article in Journal of virus eradication, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

P ZangariAcademic Department of Pediatrics (DPUO), Research Unit in Congenital and Perinatal Infection, Immune and Infectious Diseases Division, Children's Hospital Bambino Gesù (OPBG), Rome, Italy.
P PalmaAcademic Department of Pediatrics (DPUO), Research Unit in Congenital and Perinatal Infection, Immune and Infectious Diseases Division, Children's Hospital Bambino Gesù (OPBG), Rome, Italy.
N CotugnoAcademic Department of Pediatrics (DPUO), Research Unit in Congenital and Perinatal Infection, Immune and Infectious Diseases Division, Children's Hospital Bambino Gesù (OPBG), Rome, Italy.
P RojoDepartment of Pediatrics, Hospital 12 de Octubre, Madrid, Spain.
A TagarroDepartment of Pediatrics, Hospital 12 de Octubre, Madrid, Spain.
I PepponiAcademic Department of Pediatrics (DPUO), Research Unit in Congenital and Perinatal Infection, Immune and Infectious Diseases Division, Children's Hospital Bambino Gesù (OPBG), Rome, Italy.
A De RossiSection of Oncology and Immunology, Department of Surgery, Oncology and Gastroenterology-DiSCOG, University of Padova, and Istituto Oncologico Veneto, Padova, Italy.
L KuhnGertrude H Sergievsky Center, College of Physicians and Surgeons and Department of Epidemiology, Mailman School of Public Health, Columbia University Medical Center, New York, NY, USA.
S PahwaDepartment of Microbiology and Immunology, Miami Center for AIDS Research, University of Miami, Miller School of Medicine, Miami, FL, USA.
M CameronDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, USA.
E NastouliDepartment of Virology, University College London Hospitals, London, UK.
S WattersInfection, Inflammation and Rheumatology Section, University College London Great Ormond Street Institute of Child Health, London, UK.
A G MarcelineSorbonne University, UPMC University of Paris 6, Service de Virologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
L E McCoyDivision of Infection and Immunity, University College London, UK.
D PersaudDepartment of Pediatrics, Division of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, MA, USA.
A ViolariPerinatal Health Research Unit, University of Witwatersrand, Johannesburg, South Africa.
M ChanMRC Clinical Trials Unit, University College London, UK.
A G BabikerMRC Clinical Trials Unit, University College London, UK.
C FosterImperial College Healthcare National Health Service Trust, London, UK.
J AnanworanichHenry M Jackson Foundation for the Advancement of Military Medicine, MA, USA.
C GiaquintoDepartment of Women's and Child's Health, Paediatric Infectious Diseases Unit, University of Padova and PENTA Foundation, Padova, Italy.
P RossiAcademic Department of Pediatrics (DPUO), Research Unit in Congenital and Perinatal Infection, Immune and Infectious Diseases Division, Children's Hospital Bambino Gesù (OPBG), Rome, Italy.

Funding

WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Sharon L. Hillier, JONATHAN KARN · 1994 to 2026
$50.0M
NIAID NIH HHS P30 AI036219
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID29568555
PMCPMC5851186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.